Rxcurve
HCPCS J3260 · per 80 MG

Tobramycin sulfate injection

Products billed under this code include Tobramycin, Tobramycin Sulfate.

Payment limit per 80 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J3260

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Tobramycin Xiromed, LLC 70700-0173-22 15 $35.175
Tobramycin Sulfate Pfizer Inc 00409-3578-01 25 $58.625
Tobramycin Sulfate Baxter Healthcare Corporation 36000-0242-01 15 $35.175
Tobramycin Sulfate Baxter Healthcare Corporation 36000-0244-25 25 $58.625
Tobramycin Sulfate XGen Pharmaceuticals DJB, Inc. 39822-0412-01 15 $35.175
Tobramycin Sulfate XGen Pharmaceuticals DJB, Inc. 39822-0412-06 90 $211.05
Tobramycin Sulfate Eugia US LLC 55150-0470-06 90 $211.05
Tobramycin Sulfate FreseniUS Kabi USA, LLC 63323-0303-51 90 $211.05
Tobramycin Sulfate FreseniUS Kabi USA, LLC 63323-0303-55 90 $211.05
Tobramycin Sulfate FreseniUS Kabi USA, LLC 63323-0305-02 7 $16.415
Show all 19 products
ProductLabelerNDCUnits / pkgLimit / pkg
Tobramycin Sulfate FreseniUS Kabi USA, LLC 63323-0306-02 25 $58.625
Tobramycin Sulfate FreseniUS Kabi USA, LLC 63323-0306-30 150 $351.75
Tobramycin Sulfate Mylan Institutional LLC 67457-0428-30 150 $351.75
Tobramycin Sulfate Mylan Institutional LLC 67457-0473-22 25 $58.625
Tobramycin Sulfate Slate Run Pharmaceuticals 70436-0110-56 90 $211.05
Tobramycin Sulfate Slate Run Pharmaceuticals 70436-0110-80 15 $35.175
Tobramycin Sulfate Xiromed, LLC 70700-0173-86 90 $211.05
Tobramycin Sulfate Fosun Pharma USA Inc. 72266-0163-06 90 $211.05
Tobramycin Sulfate Northstar RxLLC 72603-0160-06 90 $211.05

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $2.345 +$0.159 80 MG Tobramycin sulfate injection v1, posted September 17, 2026
3Q26 $2.186 +$0.167 80 MG Tobramycin sulfate injection v1, posted September 15, 2026
2Q26 $2.019 −$0.052 80 MG Tobramycin sulfate injection v1, posted September 15, 2026
1Q26 $2.071 −$0.302 80 MG Tobramycin sulfate injection v1, posted September 15, 2026
4Q25 $2.373 −$0.087 80 MG Tobramycin sulfate injection v1, posted September 8, 2026
3Q25 $2.46 +$0.865 80 MG Tobramycin sulfate injection v1, posted March 10, 2026
2Q25 $1.595 −$0.371 80 MG Tobramycin sulfate injection v1, posted March 10, 2026
1Q25 $1.966 −$0.304 80 MG Tobramycin sulfate injection v1, posted December 19, 2025
4Q24 $2.27 −$0.118 80 MG Tobramycin sulfate injection v1, posted June 11, 2025
3Q24 $2.388 −$0.165 80 MG Tobramycin sulfate injection v1, posted June 11, 2025
2Q24 $2.553 −$0.111 80 MG Tobramycin sulfate injection v1, posted March 11, 2025
1Q24 $2.664 +$0.013 80 MG Tobramycin sulfate injection v1, posted December 19, 2024
4Q23 $2.651 −$0.001 80 MG Tobramycin sulfate injection v1, posted October 10, 2024
3Q23 $2.652 +$0.317 80 MG Tobramycin sulfate injection v1, posted June 5, 2024
2Q23 $2.335 −$0.382 80 MG Tobramycin sulfate injection v1, posted February 23, 2024
1Q23 $2.717 +$0.116 80 MG Tobramycin sulfate injection v1, posted December 6, 2023
4Q22 $2.601 +$0.364 80 MG Tobramycin sulfate injection v1, posted June 22, 2023
3Q22 $2.237 +$0.047 80 MG Tobramycin sulfate injection v1, posted June 9, 2023
2Q22 $2.19 −$1.928 80 MG Tobramycin sulfate injection v1, posted December 14, 2022
1Q22 $4.118 +$0.277 80 MG Tobramycin sulfate injection v1, posted June 8, 2022
4Q21 $3.841 −$0.212 80 MG Tobramycin sulfate injection v1, posted June 2, 2022
3Q21 $4.053 −$0.889 80 MG Tobramycin sulfate injection v1, posted June 2, 2022
2Q21 $4.942 +$0.345 80 MG Tobramycin sulfate injection v1, posted March 1, 2022
1Q21 $4.597 – 80 MG Tobramycin sulfate injection v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files